TGTX icon

TG Therapeutics
TGTX

Overview Fund Trends Analyst Outlook Journalist POV

135 hedge funds and large institutions have $646M invested in TG Therapeutics in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

17% more funds holding

Funds holding: 115 → 135 (+20)

7.39% more ownership

Funds ownership: 51.06% → 58.45% (+7.4%)

Holders
135
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$35.8M
Puts
$8.12M
Net Calls
Net Calls Change

Top Buyers

1
+$60.3M
2
+$33.3M
3
+$11.9M
4
ACA
Avoro Capital Advisors
New York
+$11.1M
5
Alkeon Capital Management
Alkeon Capital Management
New York
+$11.1M

Top Sellers

1
-$49.1M
2
-$10.2M
3
-$5.98M
4
State Street
State Street
Massachusetts
-$5.61M
5
BM
Bridger Management
New York
-$4.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4.42M
27
$3.6M
28
$3.57M
29
$3.51M
30
$3.48M
31
$3.46M
32
$3.08M
33
$2.81M
34
$2.75M
35
$2.54M
36
$2.18M
37
$2M
38
$1.88M
39
$1.81M
40
$1.78M
41
$1.78M
42
$1.63M
43
$1.46M
44
$1.46M
45
$1.31M
46
$1.23M
47
$1.23M
48
$1.19M
49
$1.13M
50
$1.11M
1
2
3 4 5